Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Healthcare & Medical Investment's Return-on-Tangible-Asset or its related term are showing as below:
TSE:3455'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 2.24 Med: 2.61 Max: 2.91
Current: 2.41
During the past 11 years, Healthcare & Medical Investment's highest Return-on-Tangible-Asset was 2.91%. The lowest was 2.24%. And the median was 2.61%.
TSE:3455's Return-on-Tangible-Asset is ranked worse than 60.39% of 924
companies
in the REITs industry
Industry Median: 3.32
vs TSE:3455: 2.41
Healthcare & Medical Investment (TSE:3455) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Healthcare & Medical Investment Return-on-Tangible-Asset Related Terms
Healthcare & Medical Investment Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healthcare & Medical Investment Return-on-Tangible-Asset Chart
TSE:3455 vs WELL, VTR, DOC: Return-on-Tangible-Asset Comparison
For the REIT - Healthcare Facilities subindustry, Healthcare & Medical Investment's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healthcare & Medical Investment Return-on-Tangible-Asset vs REITs Industry
For the REITs industry and Real Estate sector, Healthcare & Medical Investment's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Healthcare & Medical Investment's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jan. 2026) net income data.
What does a Return-on-Tangible-Asset of 2.44% mean?
Healthcare & Medical Investment (TSE:3455) has a Return-on-Tangible-Asset of 2.44% as of Jan. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Healthcare & Medical Investment and its competitors. This is near median its historical median of 2.61. Over the past decade, Healthcare & Medical Investment's Return-on-Tangible-Asset has ranged from 2.24 to 2.91. According to the industry distribution chart, Healthcare & Medical Investment ranks #558 out of 924 companies in the REITs industry, placing it in the top 60.4%.
Is Healthcare & Medical Investment's Return-on-Tangible-Asset too high?
Healthcare & Medical Investment's current Return-on-Tangible-Asset of 2.44% is near median its 10-year median of 2.61. Over the past 10 years, this metric has ranged from a low of 2.24 to a high of 2.91. The REITs industry median Return-on-Tangible-Asset is 3.32. Healthcare & Medical Investment's value of 2.44% is 26.5% below this industry median. Based on the distribution chart, Healthcare & Medical Investment ranks #558 out of 924 companies in the REITs industry, which is below the industry midpoint. Overall, Healthcare & Medical Investment has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's Return-on-Tangible-Asset compare to WELL and VTR?
According to the REITs industry distribution chart, Healthcare & Medical Investment ranks #558 out of 924 companies for Return-on-Tangible-Asset. This places Healthcare & Medical Investment in the lower half of its industry. The industry median Return-on-Tangible-Asset is 3.32. Healthcare & Medical Investment's value of 2.44% is 26.5% below this benchmark. Historically, Healthcare & Medical Investment's own Return-on-Tangible-Asset has ranged from 2.24 to 2.91 over the past decade. While the company's 10-year median is 2.61 vs. the industry median of 3.32, Healthcare & Medical Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a REITs company?
The median Return-on-Tangible-Asset among REITs companies is 3.32, based on 924 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healthcare & Medical Investment's current Return-on-Tangible-Asset of 2.44% is 26.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Healthcare & Medical Investment and its competitors. For the REITs industry, the median Return-on-Tangible-Asset is 3.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healthcare & Medical Investment's current Return-on-Tangible-Asset is 2.44%, which is near median its own 10-year median of 2.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,510.37, compared to a current price of 円96,100.00 — trading 25.8% below its estimated fair value. The current Return-on-Tangible-Asset is 2.44%, which is near median its 10-year median of 2.61 and 26.5% below the REITs industry median of 3.32. Healthcare & Medical Investment's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current Return-on-Tangible-Asset is 2.44% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?
Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued.
The current stock price of 円96,100.00 is trading 25.8% below its estimated GF Value™ of 円129,510.37.
GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.
Key valuation signals for TSE:3455:
Return-on-Tangible-Asset: 2.44% (near median its 10-year median of 2.61)
GF Value™: 円129,510.37 vs. price of 円96,100.00 (25.8% below fair value)
Industry Position: 26.5% below the REITs median (#558 of 924)
No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
50GF Score
Get the complete analysis for TSE:3455
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3455 has been successfully added to your 
